ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voelkel, N.F.
Right arrow Articles by Cool, C.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voelkel, N.F.
Right arrow Articles by Cool, C.D.
Eur Respir J 2003; 22:28S-32S
Copyright ©ERS Journals Ltd 2003


Pulmonary vascular involvement in chronic obstructive pulmonary disease

N.F. Voelkel and C.D. Cool

Pulmonary Hypertension Center and Dept of Pathology, University of Colorado, Health Sciences Center, Denver, Colorado, USA

CORRESPONDENCE: N.F. Voelkel, Division of Pulmonary Sciences and Critical Care Medicine, 4200 E. Ninth Avenue, C272, Denver, CO 80262. Fax: 1 303 3155632. E-mail: norbert.voelkel@uchsc.edu

Keywords: apoptosis, chronic obstructive pulmonary disease, emphysema, lung vascular remodelling, oxidative stress, vascular endothelial growth factor

Received: June 30, 2003
Accepted June 30, 2003

Chronic obstructive lung disease affects the entire lung, not just the airways. Although pulmonary hypertension (PH) has long been recognised in a subset of patients with COLD, the important pathophysiological questions remain unanswered. Oxygen supplementation, however, has been shown to blunt the exercise-induced PH in these patients. Hypercoagulability has also been described in patients with COLD. This may, in part, be due to the inflammatory aspects of COLD exacerbation events. In addition to perivascular inflammation, the pathology of vessels in COLD includes intimal thickening, muscularisation of arterioles, in situ thrombosis, loss of capillaries and precapillary arterioles, and vascular congestion and stasis. Recent work describes apoptosis of septal endothelial cells and decreased expression of vascular endothelial growth factor (VEGF) and one of its receptors, VEGFRII, in lungs from patients with emphysema. Based on this work, a rat model was developed that shows chronic blockade of VEGF receptors leads to septal cell apoptosis and results in emphysema and PH. This animal model has led to prevention trials using 1) a broad-spectrum caspase inhibitor, 2) a superoxide dismutase mimetic, and 3) {alpha}1-antitrypsin.

These findings highlight the importance of vascular endothelial growth factor, apoptosis, oxidative stress and protease activity in the pathogenesis of emphysema. They also underscore the importance of the vasculature in what is traditionally thought of as an airways disease. Future treatment strategies need to address the vascular components of chronic obstructive lung disease.




This article has been cited by other articles:


Home page
Eur Respir JHome page
K. Nagai, T. Betsuyaku, Y. Ito, Y. Nasuhara, and M. Nishimura
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Eur. Respir. J., April 1, 2005; 25(4): 626 - 633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.